Astellas Pharma (ALPMF) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Astellas Pharma (ALPMF) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Astellas Pharma

· ALPMF

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

26.379 B

-7.14%

General

Market Cap: $26.38B
Enterprise Value: $4.49T
Shares Outstanding: 1,809,660,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 79.65%
Operating Margin: 18.15%
Net Profit Margin: 6.22%
FCF Margin: 18.53%
ROA: 9.88%
ROE: 20.41%
ROIC: 14.04%
Current Ratio: 1.20
Debt-to-Equity: 0.46
Revenue Per Employee: —

Valuation (TTM)

P/E: 11.36
PEG: -1.50
P/S: —
P/FCF: 7.66
P/B: —
EV/EBITDA: 6.63

Growth

Rev 1Y: 33.40%
Rev 1Y Fwd Est: 8.92%
Rev 3Y (CAGR): 18.18%
Rev 5Y (CAGR): 10.46%
Rev 10Y (CAGR): 4.54%
EPS 1Y: 1612.99%
EPS 1Y Fwd Est: 22.86%
EPS 3Y (CAGR)

Income Statement (TTM)

Revenue: $12.69B
Gross Margin: 79.65%
Operating Expenses: $7.8B
Operating Income: $2.3B
Net Profit: $789.49M

Balance Sheet

34.25%

EPS 5Y (CAGR)

9.28%

EPS 10Y (CAGR)

6.11%

Cash and Equivalents: $1.81B
Working Capital: $274.25M
Total Assets: $21.81B
Net Debt: $2.87B
Total Liabilities: $11.62B
Total Equity: $10.19B

Cash Flow Statement (TTM)

Cash Flow from Operations: $2.56B
Cash Flow from Investing: -$440.13M
Cash Flow from Financing: -$2.22B
Free Cash Flow: $2.35B
Capital Expenditures: $212.74M